Azitra is trading at $1.21 (-20.66%), with no confirmed company-specific announcement explaining the decline.

  • Its latest company release, dated October 16, announced a reverse split effective October 26.
  • Positive ex vivo ATR-COSF results and an ATM-sales pause were reported October 26, but coverage does not link them to the October 27 drop.
  • The prior-session move followed the split-adjusted trading transition; this does not establish a cause for October 27’s decline. Trading volume information was not provided.